THAP12P9

Across TCGA pan-cancer cohorts, THAP12P9 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated THAP12P9 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher THAP12P9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated THAP12P9 expression acts as an unfavorable survival marker.

LIHC, LGG, and OV are the cancer types where THAP12P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.059	0.774	<.001	72	view →
LGG	OS	Tertile	All	0.408	0.808	<.001	36	view →
OV	DFS	Tertile	II,III,IV	0.243	0.385	.027	36	view →
LUAD	DFS	Tertile	IV	0.047	0.565	<.001	36	view →
KIRC	OS	Tertile	All	0.734	0.815	.013	18	view →
GBM	OS	Tertile	All	0.074	0.419	<.001	18	view →
LUSC	DFS	Tertile	II,III,IV	0.139	0.663	.027	9	view →
BLCA	OS	Tertile	IV	0.141	0.573	.034	9	view →
UCEC	OS	Tertile	All	0.871	0.931	.049	6	view →
KIRP	OS	Tertile	All	0.212	0.707	.049	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

THAP12P9–LIHC (OS)

Open the LIHC breakdown →